mesalamine has been researched along with Acute Generalised Exanthematous Pustulosis in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
"Mesalamine was discontinued, and thepatient's skin eruption, renal function, liver functiontests, and leukocytosis subsequently improved." | 1.46 | First report of mesalamine (5-aminosalicylic acid) as the causative agent in a case of acute generalized exanthamous pustulosis. ( Hutchens, K; Park, K; Rocci, E; Winterfield, L, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rocci, E | 1 |
Park, K | 1 |
Hutchens, K | 1 |
Winterfield, L | 1 |
1 other study available for mesalamine and Acute Generalised Exanthematous Pustulosis
Article | Year |
---|---|
First report of mesalamine (5-aminosalicylic acid) as the causative agent in a case of acute generalized exanthamous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, | 2017 |